KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cognex (CGNX) EBT (2016 - 2026)

Cognex filings provide 17 years of EBT readings, the most recent being $44.1 million for Q4 2025.

  • On a quarterly basis, EBT rose 23.13% to $44.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $182.8 million, a 39.02% increase, with the full-year FY2025 number at $182.8 million, up 39.02% from a year prior.
  • EBT hit $44.1 million in Q4 2025 for Cognex, down from $62.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $93.5 million in Q3 2021 to a low of $14.4 million in Q4 2023.
  • Median EBT over the past 5 years was $46.1 million (2025), compared with a mean of $51.0 million.
  • Biggest five-year swings in EBT: surged 4145.76% in 2021 and later tumbled 75.77% in 2023.
  • Cognex's EBT stood at $57.9 million in 2021, then increased by 2.22% to $59.2 million in 2022, then tumbled by 75.77% to $14.4 million in 2023, then soared by 149.41% to $35.8 million in 2024, then rose by 23.13% to $44.1 million in 2025.
  • The last three reported values for EBT were $44.1 million (Q4 2025), $62.9 million (Q3 2025), and $48.1 million (Q2 2025) per Business Quant data.